Table 3.
Patients treated with antipsychotics and treatment adherence
| Drug | n | % patients | Adherence | CI 95% | P-value | ||
|---|---|---|---|---|---|---|---|
| Minimum | Mean | Maximum | |||||
| SGAs | |||||||
| Aripiprazole | 43 | 7.6 | 7.78 | 62.07 | 100 | 22.6 - 80.1 | 0.01 |
| Olanzapine | 193 | 34.2 | 7.78 | 59.15 | 100 | 25.9 - 81.2 | 0.01 |
| Quetiapine | 156 | 27.7 | 8.33 | 66.68 | 100 | 27.9 - 88.5 | 0.01 |
| Risperidone | 109 | 19.3 | 8.33 | 59.75 | 100 | 29.3 -84.3 | 0.01 |
| Clozapine | 19 | 3.4 | 7.8 | 51.80 | 100 | 29.7 - 85.2 | 0.01 |
| FGAs | |||||||
| Haloperidol | 26 | 4.6 | 8.33 | 63.99 | 100 | 17.4 - 59.2 | 0.01 |
| Clotiapine | 8 | 1.4 | 16 | 66.38 | 100 | 24.3 - 96.5 | 0.01 |
| Levomepromazine | 6 | 1.1 | 33.33 | 68.06 | 100 | 32.8 - 87.9 | 0.01 |
| Clorpromazine | 4 | 0.7 | 22.22 | 69.44 | 100 | 20.4 - 80.0 | 0.01 |
SGA, second-generation antipsychotics;
FGA, first-generation antipsychotic.